Skip to content

Clinical trials

Terminated Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Terminated Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20111
20142
20151
20171
20181
20191
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
European Organisation for Research and Treatment of Cancer - EORTC2
Amgen1
Bristol-Myers Squibb1
Celgene1
Hoffmann-La Roche1
Hospices Civils de Lyon1
Janssen Research & Development, LLC1
Kiadis Pharma1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Leukemia, Myeloid, Acute5
Leukemia4
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Myelodysplastic Syndromes3
Burkitt Lymphoma2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.